ISCO Insider Trading Activity and SEC Form 4 Filings
ISCO insider trading summary
Over the past 12 months, insiders at International Stem Cell CORP (ISCO) reported 1 sale worth $10K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $10K.
Latest ISCO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Paul V Maier | Director | Sell | $10K (32,802 @ $0.32) |
| Aug 6, 2014 | Ruslan Semechkin | Chief Scientific Officer | Buy | $100K (1,000,000 @ $0.10) |
| Jan 22, 2013 | Andrey Semechkin | Chief Executive Officer | Buy | $2.0M (10,000,000 @ $0.20) |
| Jan 22, 2013 | John Simon Craw | Executive Vice President | Buy | $0 (125,000 @ $0.00) |
| Oct 6, 2008 | Edward O Hunter | Director | Buy | $1K (5,000 @ $0.22) |
| Oct 6, 2008 | Edward O Hunter | Director | Buy | $1K (5,000 @ $0.20) |
| Jun 17, 2008 | Edward O Hunter | Director | Buy | $1K (3,000 @ $0.34) |
| Jun 16, 2008 | Edward O Hunter | Director | Buy | $2K (5,000 @ $0.34) |
| Jun 3, 2008 | Edward O Hunter | Director | Buy | $720 (2,000 @ $0.36) |
| May 30, 2008 | Edward O Hunter | Director | Buy | $925 (2,500 @ $0.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.